HeartSciences Inc. (HSCS)
NASDAQ: HSCS · Real-Time Price · USD
3.730
+0.370 (11.01%)
At close: Sep 4, 2026, 4:00 PM EDT
3.750
+0.020 (0.54%)
After-hours: Sep 4, 2026, 7:59 PM EDT
HeartSciences Revenue
In the fiscal year ending April 30, 2026, HeartSciences had annual revenue of $4.32K, down -0.71%.
Revenue (ttm)
$4.32K
Revenue Growth
-0.71%
P/S Ratio
3,367.70
Revenue / Employee
$309
Employees
14
Market Cap
14.55M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Apr 30, 2026 | 4.32K | -31.00 | -0.71% |
| Apr 30, 2025 | 4.35K | -14.25K | -76.61% |
| Apr 30, 2024 | 18.60K | 13.45K | 261.17% |
| Apr 30, 2023 | 5.15K | -9.22K | -64.17% |
| Apr 30, 2022 | 14.37K | -11.23K | -43.86% |
| Apr 30, 2021 | 25.60K | -38.58K | -60.11% |
| Apr 30, 2020 | 64.18K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| IRIDEX | 51.57M |
| Trinity Biotech | 43.79M |
| Cytosorbents | 37.22M |
| Lifeward | 21.82M |
| Pulsenmore | 14.13M |
| NeuroOne Medical Technologies | 12.47M |
| Picard Medical | 6.30M |
| Biomerica | 4.45M |
HSCS News
- 1 day ago - HeartSciences Proxy statement: Proxy filing - Filings
- 1 day ago - HeartSciences Proxy statement: Proxy filing - Filings
- 2 days ago - HeartSciences Proxy statement: Proxy filing - Filings
- 3 days ago - HeartSciences Proxy statement: Proxy filing - Filings
- 4 days ago - HeartSciences Proxy statement: Proxy filing - Filings
- 5 days ago - HeartSciences Proxy statement: Proxy filing - Filings
- 5 days ago - HeartSciences Proxy statement: Proxy filing - Filings
- 8 days ago - HeartSciences Proxy statement: Proxy filing - Filings